Corteva, Inc.
NYSE:CTVAAgricultural Inputs
+$0.72 today
- Market cap
- $5.58B
- Beta
- 0.57
- P/E (TTM)
- 45.2
- EPS (TTM)
- $1.73
- Dividend yield
- 0.92%
Volume 22.41M
Average 3.82M
CTVA Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Corteva, Inc.NYSE: CTVA
Accounts Payables · Q3 FY2026 · quarter ended Sep 2026
Accounts payables declines year over year
Q3 FY2026 accounts payables of $440M fell 8.1% year over year, ahead of the -88.4% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at -34.1% a year.
Context
- Accounts payables amounted to 1.3% of revenue in FY2025, up 0.6 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -8.1% holds above the trailing-twelve-month pace of -88.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 231M USD
- Year-over-year change
- +300.9%
- 4-year CAGR
- -18.5%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 231M | +300.9% |
| FY2024 | 2024-12-31 | (115M) | +82.7% |
| FY2023 | 2023-12-31 | (663M) | -182.2% |
| FY2022 | 2022-12-31 | 807M | +54.0% |
| FY2021 | 2021-12-31 | 524M | — |
Accounts Payables vs competitors
How CTVA compares with its peers on the latest reported figures
- CTVA's LTM Sep 2026 accounts payables of $61M is the 4th largest of the 7 companies compared; the peer median is $28.17M.
- Its year-over-year change of -88.4% is the 2nd highest of 6, against a peer median of -88.4%.
- Accounts payables amounts to 0.3% of revenue for CTVA, versus a peer median of 0.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $117.89M | — | — | 0.4% | |
| LTM Mar 2026 | $110.4M | -275.5% | -50.5% | 3.2% | |
VYLRVylor Inc. | FY2025 | $104M | +168.4% | — | 1.0% |
| LTM Sep 2026 | $61M | -88.4% | -34.1% | 0.3% | |
| LTM Sep 2026 | $61M | -88.4% | -34.1% | 0.3% | |
| LTM Sep 2026 | $61M | -88.4% | -34.1% | 0.3% | |
| LTM Mar 2026 | $4.66M | -114.3% | +108.5% | 0.9% | |
| Peer median (excluding CTVA) | $28.17M | -88.4% | -34.1% | 0.7% | |
Competitors are the stored peer set for CTVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.82B | 1.21B | 941M | 863M | 1.11B |
| Depreciation & Amortization | 1.24B | 1.22B | 1.21B | 1.23B | 1.2B |
| Deferred Income Tax | 174M | (286M) | (438M) | (365M) | (41M) |
| Stock-Based Compensation | 0 | 55M | 0 | 0 | 0 |
| Change in Working Capital | 656M | (1.55B) | (786M) | (92M) | 540M |
| Accounts Receivables | (113M) | (997M) | 358M | (705M) | (261M) |
| Inventory | (422M) | (1.72B) | 57M | 1.11B | (35M) |
| Accounts Payables | 524M | 807M | (663M) | (115M) | 231M |
| Other Working Capital | 667M | 356M | (538M) | (382M) | 605M |
| Other Non-Cash Items | (1.17B) | 224M | 841M | 512M | 599M |
| Operating Cash Flow | 2.73B | 872M | 1.77B | 2.15B | 3.41B |
| Capital Expenditures | (573M) | (605M) | (595M) | (597M) | (591M) |
| Acquisitions (Net) | (4M) | (12M) | (1.46B) | (7M) | (20M) |
| Purchases of Investments | (204M) | (344M) | (148M) | (144M) | (83M) |
| Sales of Investments | 345M | 295M | 167M | 193M | 135M |
| Other Investing Activities | 74M | 34M | 45M | (34M) | 16M |
| Investing Cash Flow | (362M) | (632M) | (1.99B) | (589M) | (543M) |
| Debt Repayment | 11M | 205M | 1.11B | 240M | (141M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 88M |
| Common Stock Repurchased | (950M) | (1B) | (756M) | (1.01B) | (1.07B) |
| Dividends Paid | (397M) | (418M) | (439M) | (458M) | (475M) |
| Other Financing Activities | 70M | 33M | (18M) | 28M | (45M) |
| Financing Cash Flow | (1.27B) | (1.18B) | (99M) | (1.2B) | (1.64B) |
| Effect of Forex Changes | (136M) | (278M) | (143M) | (93M) | (120M) |
| Net Change in Cash | 963M | (1.22B) | (460M) | 264M | 1.1B |
| Free Cash Flow | 2.15B | 267M | 1.17B | 1.55B | 2.82B |
Corteva, Inc.
NYSE:CTVA
Intrinsic Alpha fair value
Locked
Current Price
$8.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.